PM
52
-4
TDC
47
-2
NWL
32
-3
TRV
64
-3
TGT
50
2
VFC
57
4
LEG
29
4
FLS
46
-7
EIX
69
-5
AVY
54
-14
AAL
47
-3
BAX
35
-3
SBUX
41
-3
TJX
50
2
DOV
63
-6
HES
59
3
BAC
39
-2
HPE
53
2
BBY
59
7
RIG
35
-3
PM
52
-4
TDC
47
-2
NWL
32
-3
TRV
64
-3
TGT
50
2
VFC
57
4
LEG
29
4
FLS
46
-7
EIX
69
-5
AVY
54
-14
AAL
47
-3
BAX
35
-3
SBUX
41
-3
TJX
50
2
DOV
63
-6
HES
59
3
BAC
39
-2
HPE
53
2
BBY
59
7
RIG
35
-3
Financhill
Back

Entrada Therapeutics Vs. Fulcrum Therapeutics Industry Stock Comparison

Sell
37

TRDA
Entrada Therapeutics

Last Price:
15.14
Seasonality Move:
13.84%
Sell
1

FULC
Fulcrum Therapeutics

Last Price:
3.56
Seasonality Move:
-0.93%
Sell
37
Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $13.66. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Fulcrum Therapeutics (FULC) is a Sell

Is Fulcrum Therapeutics a Buy, Sell or Hold?

  • The current Fulcrum Therapeutics [FULC] share price is $3.44. The Score for FULC is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • FULC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $13.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.

FULC Stock Price Chart

What is Fulcrum Therapeutics's stock price today?

  • The Fulcrum Therapeutics share price today is $3.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing slight selling pressure.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 34.17 Sell
Chaikin Money Flow: -107441 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.74 - 16.8) Sell
Bollinger Bands (100): (14.08 - 16.6) Sell

FULC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.33 Sell
Relative Strength Index (14 RSI): 24.25 Sell
Chaikin Money Flow: -65859 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.54 - 10.08) Sell
Bollinger Bands (100): (6.37 - 9.11) Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.6 Sell
20-day SMA: 15.61 Sell
50-day SMA: 15.96 Sell
200-day SMA: 14.67 Sell
8-day EMA: 14.57 Sell
20-day EMA: 15.2 Sell
50-day EMA: 15.49 Sell
200-day EMA: 14.99 Sell

FULC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.33 Sell
20-day SMA: 7.42 Sell
50-day SMA: 8.19 Sell
200-day SMA: 7.89 Sell
8-day EMA: 4.87 Sell
20-day EMA: 6.61 Sell
50-day EMA: 7.59 Sell
200-day EMA: 7.49 Sell

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.

Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.15 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fulcrum Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):